| PACKAGING TYPE: | 10x10 Strip ( 10 Strip In 1 Box ) |
| FORMULATION: | Tablet |
| Description: | CLOPINASE AP 150 Tablet is a dual antiplatelet formulation containing Clopidogrel 75 mg (as Clopidogrel bisulphate) and Aspirin 150 mg. It is used to prevent the formation of blood clots in patients at high risk of cardiovascular events such as heart attack and stroke. Clopidogrel works by inhibiting ADP-mediated platelet aggregation, while Aspirin blocks cyclooxygenase (COX), reducing platelet activation. This higher-dose Aspirin combination provides enhanced antiplatelet efficacy, especially in high-risk patients and post-cardiac procedures. |
| Side Effects: | Some individuals may experience: Increased bleeding or bruising Gastric irritation or acidity Nausea Indigestion Headache Serious side effects (rare) include gastrointestinal bleeding, black stools, or severe allergic reactions—seek immediate medical attention if these occur. |
| How to Use: | Take the tablet as prescribed by a healthcare professional. Swallow whole with water, preferably after meals. Take at the same time each day. Do not skip doses for optimal protection. Follow the prescribed duration strictly. |
| Precaution: | Use cautiously in patients with peptic ulcers or bleeding disorders. Inform your doctor before any surgery or dental procedures. Avoid concurrent use with other anticoagulants or NSAIDs unless prescribed. Monitor for signs of unusual bleeding or stomach pain. Pregnant or breastfeeding women should consult a healthcare professional before use. Avoid alcohol to reduce risk of gastric irritation and bleeding. |
| Product Benefits: | Provides strong dual antiplatelet action. Reduces risk of heart attack and stroke. Beneficial after angioplasty and stent placement. Improves arterial blood flow. Suitable for high-risk cardiovascular patients. |
Frequently Asked Questions
It is used to prevent blood clots, heart attacks, and strokes, especially in high-risk patients.
It contains a higher dose of Aspirin (150 mg), providing stronger antiplatelet action.
Yes, due to dual antiplatelet action, there is an increased risk of bleeding and bruising.










